Skin Substitutes, Wound Care, and Cellular & Tissue-Based Products (CTP)
Skin Substitutes, Wound Care, and Cellular & Tissue-Based Products (CTP)
As the skin substitutes and advanced wound care industry experiences rapid growth, it has become the focus of increased government scrutiny, evolving reimbursement requirements and heightened enforcement activity. Manufacturers, providers, investors and other industry participants face a growing number of legal and business challenges involving reimbursement, compliance, government investigations, False Claims Act enforcement and strategic transactions.
To help clients navigate this evolving landscape, Bass, Berry & Sims launched the nation's first dedicated multidisciplinary Skin Substitutes, Wound Care and Cellular & Tissue-Based Products (CTP) Task Force focused on the legal, regulatory and enforcement issues affecting advanced wound care products.
The Task Force includes attorneys from the firm's nationally recognized healthcare regulatory, healthcare fraud and abuse, government investigations, litigation and transactional practices. We advise manufacturers, providers, investors and others throughout the wound care ecosystem on the legal, regulatory and business issues affecting skin substitutes, advanced wound care products and CTPs.
How We Help Clients
We counsel clients on:
- Government investigations, audits and enforcement actions
- False Claims Act and other healthcare litigation
- Internal investigations and compliance counseling
- Medicare and commercial reimbursement matters
- Anti-Kickback Statute, Stark Law and sales and marketing compliance
- Mergers, acquisitions and strategic transactions
- Regulatory due diligence and risk assessments
What Sets Us Apart
Dedicated Industry Focus
Our attorneys are actively involved in some of the industry's most novel and high-stakes matters involving skin substitutes, wound care services and CTPs. This experience gives us firsthand insight into evolving reimbursement policies, enforcement priorities and market developments, allowing us to help clients anticipate risks, respond to challenges and identify opportunities in a rapidly changing environment.
Reimbursement and Regulatory Knowledge
As regulatory counsel to more than 200 healthcare companies nationwide, Bass, Berry & Sims brings extensive experience navigating Medicare and commercial reimbursement issues, coverage and payment policies, compliance obligations and operational challenges. This depth of knowledge allows us to provide practical guidance that addresses both legal risk and business objectives in the rapidly evolving skin substitutes, wound care services and CTP industries.
Government Insight
Many of our attorneys previously held leadership roles within the U.S. Department of Justice (DOJ), the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG), the Centers for Medicare & Medicaid Services (CMS) and other government agencies. This experience provides valuable insight into government priorities, investigative strategies and enforcement approaches while enhancing our credibility with regulators.
Whether responding to a government investigation, navigating reimbursement challenges, evaluating a strategic transaction or developing a compliance strategy, our Skin Substitutes, Wound Care and Cellular & Tissue-Based Products (CTP) Task Force helps clients manage risk and capitalize on opportunities in a rapidly evolving industry.
Market-Leading Healthcare Platform
With more than 325 healthcare attorneys, Bass, Berry & Sims is ranked as the second largest healthcare law firm in the United States, according to the American Health Law Association (2026). Our healthcare practice has earned national recognition, including 11 consecutive years in Chambers USA's nationwide healthcare rankings and designation as a Law360 Healthcare Practice Group of the Year (2025). This depth of experience allows us to quickly assemble multidisciplinary teams to address emerging areas of regulatory and enforcement risk as industry priorities evolve.
As the skin substitutes and advanced wound care industry experiences rapid growth, it has become the focus of increased government scrutiny, evolving reimbursement requirements and heightened enforcement activity. Manufacturers, providers, investors and other industry participants face a growing number of legal and business challenges involving reimbursement, compliance, government investigations, False Claims Act enforcement and strategic transactions.
To help clients navigate this evolving landscape, Bass, Berry & Sims launched the nation's first dedicated multidisciplinary Skin Substitutes, Wound Care and Cellular & Tissue-Based Products (CTP) Task Force focused on the legal, regulatory and enforcement issues affecting advanced wound care products.
The Task Force includes attorneys from the firm's nationally recognized healthcare regulatory, healthcare fraud and abuse, government investigations, litigation and transactional practices. We advise manufacturers, providers, investors and others throughout the wound care ecosystem on the legal, regulatory and business issues affecting skin substitutes, advanced wound care products and CTPs.
How We Help Clients
We counsel clients on:
- Government investigations, audits and enforcement actions
- False Claims Act and other healthcare litigation
- Internal investigations and compliance counseling
- Medicare and commercial reimbursement matters
- Anti-Kickback Statute, Stark Law and sales and marketing compliance
- Mergers, acquisitions and strategic transactions
- Regulatory due diligence and risk assessments
What Sets Us Apart
Dedicated Industry Focus
Our attorneys are actively involved in some of the industry's most novel and high-stakes matters involving skin substitutes, wound care services and CTPs. This experience gives us firsthand insight into evolving reimbursement policies, enforcement priorities and market developments, allowing us to help clients anticipate risks, respond to challenges and identify opportunities in a rapidly changing environment.
Reimbursement and Regulatory Knowledge
As regulatory counsel to more than 200 healthcare companies nationwide, Bass, Berry & Sims brings extensive experience navigating Medicare and commercial reimbursement issues, coverage and payment policies, compliance obligations and operational challenges. This depth of knowledge allows us to provide practical guidance that addresses both legal risk and business objectives in the rapidly evolving skin substitutes, wound care services and CTP industries.
Government Insight
Many of our attorneys previously held leadership roles within the U.S. Department of Justice (DOJ), the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG), the Centers for Medicare & Medicaid Services (CMS) and other government agencies. This experience provides valuable insight into government priorities, investigative strategies and enforcement approaches while enhancing our credibility with regulators.
Whether responding to a government investigation, navigating reimbursement challenges, evaluating a strategic transaction or developing a compliance strategy, our Skin Substitutes, Wound Care and Cellular & Tissue-Based Products (CTP) Task Force helps clients manage risk and capitalize on opportunities in a rapidly evolving industry.
Market-Leading Healthcare Platform
With more than 325 healthcare attorneys, Bass, Berry & Sims is ranked as the second largest healthcare law firm in the United States, according to the American Health Law Association (2026). Our healthcare practice has earned national recognition, including 11 consecutive years in Chambers USA's nationwide healthcare rankings and designation as a Law360 Healthcare Practice Group of the Year (2025). This depth of experience allows us to quickly assemble multidisciplinary teams to address emerging areas of regulatory and enforcement risk as industry priorities evolve.
Experience
- Healthcare Government Enforcement
- Medical Device and Supplies/Diagnostic Services
- Physician Services
-
Bass, Berry & Sims represented a client physician in successfully securing the lifting of a Medicare payment suspension related to...
-
We represented a durable medical equipment manufacturer in a DOJ investigation into alleged FCA violations concerning the manner in which...
-
We represented BioTissue Holdings, Inc, a leader in harnessing the unique properties of human birth tissue to facilitate regenerative healing,...
-
We represented a global healthcare company in relation to an investigation conducted by DOJ and HHS-OIG into alleged violations of...
-
We represented Advanced Dermatology & Cosmetic Surgery (ADCS) in its acquisition of seven skin care and dermatology practices in 2017....
-
We represented Advanced Dermatology & Cosmetic Surgery (ADCS) in its acquisition of 15 skin and dermatology practices in 2016 across...
-
In 2015, we represented Advanced Dermatology & Cosmetic Surgery (ADCS) in its acquisition of 16 skin and dermatology practices in...
-
We represented Dermatology Solutions Group (a portfolio company of Cressey & Co.) in its acquisition of The Skin Surgery Center,...
-
In 2014, we represented Advanced Dermatology & Cosmetic Surgery (ADCS) (a portfolio company of Audax Group) in its acquisition of...
Experience
-
Bass, Berry & Sims represented a client physician in successfully securing the lifting of a Medicare payment suspension related to...
-
We represented a durable medical equipment manufacturer in a DOJ investigation into alleged FCA violations concerning the manner in which...
-
We represented BioTissue Holdings, Inc, a leader in harnessing the unique properties of human birth tissue to facilitate regenerative healing,...
-
We represented a global healthcare company in relation to an investigation conducted by DOJ and HHS-OIG into alleged violations of...
-
We represented Advanced Dermatology & Cosmetic Surgery (ADCS) in its acquisition of seven skin care and dermatology practices in 2017....
-
We represented Advanced Dermatology & Cosmetic Surgery (ADCS) in its acquisition of 15 skin and dermatology practices in 2016 across...
-
In 2015, we represented Advanced Dermatology & Cosmetic Surgery (ADCS) in its acquisition of 16 skin and dermatology practices in...
-
We represented Dermatology Solutions Group (a portfolio company of Cressey & Co.) in its acquisition of The Skin Surgery Center,...
-
In 2014, we represented Advanced Dermatology & Cosmetic Surgery (ADCS) (a portfolio company of Audax Group) in its acquisition of...
Notice
Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.
Notice
Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.
Notice
Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.
Notice
Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.
Notice
Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.
Notice
Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.
Notice
Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.
Notice
Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.
Notice
Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.
Professionals
| Name | Phone | |
|---|---|---|
|
Denise M. Barnes Member |
(202) 827-7214 | Denise.Barnes@bassberry.com |
|
Kristin M. Bohl Member |
(202) 827-2987 | kristin.bohl@bassberry.com |
|
Garrah Carter-Mason Associate |
(615) 742-7781 | garrah.cartermason@bassberry.com |
|
Krista Cooper Member |
(615) 742-7734 | kcooper@bassberry.com |
|
Matthew M. Curley Member |
(615) 742-7790 | mcurley@bassberry.com |
|
Emily E. Fountain Associate |
(615) 742-7768 | emily.fountain@bassberry.com |
|
Scott D. Gallisdorfer Member |
(615) 742-7926 | scott.gallisdorfer@bassberry.com |
|
Lisa S. Rivera Member |
(615) 742-7707 | lrivera@bassberry.com |
|
Brian D. Roark Member |
(615) 742-7753 | broark@bassberry.com |
Publications
-
May 12, 2026 | Inside the False Claims Act
-
March 25, 2026 | Firm Publication
-
February 27, 2026 | Firm Publication
Past Events
-
May 22, 2026American Bar Association
-
February 24, 2026 | WebinarBass, Berry & Sims
-
December 4, 2025 | Nashville, TennesseeBass, Berry & Sims
Media Mentions & Firm News
-
January 16, 2026 | AHLA Speaking of Health Law Podcast
Publications
-
May 12, 2026 | Inside the False Claims Act
-
March 25, 2026 | Firm Publication
-
February 27, 2026 | Firm Publication
Past Events
-
May 22, 2026American Bar Association
-
February 24, 2026 | WebinarBass, Berry & Sims
-
December 4, 2025 | Nashville, TennesseeBass, Berry & Sims
Media Mentions & Firm News
-
January 16, 2026 | AHLA Speaking of Health Law Podcast
Contact
Notice
Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.
Notice
Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.
Client feedback: "They foster excellent client relationships, are responsive at any time and are business-minded. They are able to see the bigger picture and tailor their advice accordingly." and "The lawyers at the firm are excellent and provide high-touch client service and stand out for their exceptional depth of knowledge in healthcare regulatory matters."
From Chambers USA 2026

